Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Carleton University

$30,000.00

DNA nanotechnology for biosensing and controlled release

FY 2011-12

Summary
DNA is an excellent building-block for nanotechnology due to its nanoscale dimensions, its remarkable ability to self-assemble in a predictable and programmable way, and its capacity to recognize and bind to a wide variety of target molecules. In the near future, it is conceivable that biosensors, medical diagnostics and therapeutics based on DNA nanoarchitectures and nanomachines will be in routine use. In order to achieve this aim, we will require a sound understanding of DNA as a material for nanotechnology before innovative applications can be rationally designed. This proposal outlines two complementary research streams relating to the burgeoning field of DNA nanotechnology. The first stream explores the creation of DNA nanomachines that can be fueled by changes in pH. The work done here will lead to novel strategies for developing in vivo pH sensors. The second stream investigates the incorporation of DNA aptamers, DNA strands that bind tightly and specifically to a target molecule, into nanoscale thin films. These films will be studied for their application in the field of controlled release, e.g. drug delivery systems. In the long term, these two streams will provide new insights into the use of DNA as a component of nano-constructs that will be translated into innovative strategies for biosensing, medical diagnostics, and targeted therapies.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
327324-2010
Name nom
DeRosa, Maria
Department département
Chemistry
Organization id
23
Institution établissement
Carleton University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2010
Award amount
30000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5402
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Nucleic acids
Research subject fr
Acides nucléiques
Partie
2
Nb partie
5
Application title
DNA nanotechnology for biosensing and controlled release
Keyword
NSERC
Application summary
DNA is an excellent building-block for nanotechnology due to its nanoscale dimensions, its remarkable ability to self-assemble in a predictable and programmable way, and its capacity to recognize and bind to a wide variety of target molecules. In the near future, it is conceivable that biosensors, medical diagnostics and therapeutics based on DNA nanoarchitectures and nanomachines will be in routine use. In order to achieve this aim, we will require a sound understanding of DNA as a material for nanotechnology before innovative applications can be rationally designed. This proposal outlines two complementary research streams relating to the burgeoning field of DNA nanotechnology. The first stream explores the creation of DNA nanomachines that can be fueled by changes in pH. The work done here will lead to novel strategies for developing in vivo pH sensors. The second stream investigates the incorporation of DNA aptamers, DNA strands that bind tightly and specifically to a target molecule, into nanoscale thin films. These films will be studied for their application in the field of controlled release, e.g. drug delivery systems. In the long term, these two streams will provide new insights into the use of DNA as a component of nano-constructs that will be translated into innovative strategies for biosensing, medical diagnostics, and targeted therapies.